Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework () Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, et al. Journal article, Review article First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study (2025) Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study (2024) Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, et al. Journal article Subclinical synovitis: let's discuss prognosis before treatment (2024) Yalcin-Mutlu M, Tascilar K Journal article Prevention of seronegative rheumatoid arthritis: an entity of its own (2024) Bugatti S, Schett G Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial (2023) Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, et al. Journal article Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Brandt-Jürgens J, Burmester GR, Kellner H, et al. Journal article Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. (2022) Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, et al. Journal article Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. (2022) Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, et al. Journal article